C8B

C8B encodes the beta subunit of complement component C8, a terminal-pathway component of the membrane-attack complex (MAC) gene family (PMID:8365729). The 12-exon C8B gene shares exon-structure homology with C8A and C9, placing it within the ancestral MAC gene family (PMID:8365729). In serum, the C8 beta subunit associates non-covalently with the disulfide-linked alpha-gamma subunit (encoded by C8A and C8G) to constitute the trimeric C8 complex (PMID:8365729). A heterozygous C8B missense variant (c.1625C>T; p.Thr542Ile), in combination with a C2 variant, lowers both classical and alternative pathway hemolytic activity, and the terminal-pathway functional defect is captured by reconstitution experiments in patient serum (PMID:36858027). Beyond these structural, quaternary, and functional findings, no further mechanistic detail has been characterized in the available corpus.

1. 1993 Medium

   Establishing the genomic architecture of C8B answered whether it belonged to the MAC gene family and defined its exon organization for downstream mutation analysis.

   Evidence Genomic library cloning, restriction mapping, M13 subcloning, partial exon sequencing, and PCR amplification of all 12 exons

   PMID:8365729

   Open questions at the time

   • Does not define the protein's functional domains or membrane-insertion mechanism
   • Phylogenetic relationship inferred from exon homology, not from protein-level structural analysis
2. 1993 Low

   The quaternary arrangement of C8 was framed as the beta subunit binding non-covalently to the disulfide-linked alpha-gamma dimer, situating C8B within the trimeric C8 complex.

   Evidence Stated as established protein-level fact in the context of the genomic characterization study

   PMID:8365729

   Open questions at the time

   • Stated as prior knowledge without direct experimental demonstration in this study
   • No structural model of the alpha-gamma/beta interface provided
   • Stoichiometry and binding determinants not mapped
3. 2023 Medium

   A patient-derived C8B missense variant was linked to terminal-pathway dysfunction, testing whether C8B loss-of-function impairs complement-mediated hemolysis.

   Evidence Hemolytic and classical/alternative pathway activation assays plus reconstitution of patient serum with purified C2, C8, C3, and fresh frozen plasma

   PMID:36858027

   Open questions at the time

   • Variant co-occurred with a C2 variant, complicating attribution to C8B alone
   • Reconstitution with purified C8 did not fully normalize function, leaving the precise defect unresolved
   • Single-patient observation; effect of the variant on C8 assembly or MAC formation not directly measured

• How the C8B variant alters C8 assembly, MAC formation, or membrane insertion at the molecular level remains undefined.
• No structural model of the C8 trimer or its membrane-insertion mechanism in the corpus
• Molecular consequence of p.Thr542Ile on subunit assembly not characterized